ReviewReviews in endocrine & metabolic disorders2021

Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment - A Review.

Kristy T K Lau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.